FDA product code JXM: Enzyme Immunoassay, Benzodiazepine
JXM is the FDA product code for enzyme immunoassay, benzodiazepine. It is a Class II device, regulated under 21 CFR 862.3170 and reviewed by the Clinical Toxicology panel. FDA has cleared 90 510(k) submissions under JXM, 2 in the last five years, from 42 different applicants. The average 510(k) review took 87 days (median 59); 29 days on average over the last three years. FDA has posted 81 recalls for JXM devices.
Classification
| Field | Value |
|---|---|
| Device name | Enzyme Immunoassay, Benzodiazepine |
| Device class | Class II |
| Regulation | 21 CFR 862.3170 |
| Review panel | TX — Clinical Toxicology |
| Medical specialty | Clinical Toxicology |
| Premarket route | 510(k) |
| Third-party 510(k) review eligible | Yes |
510(k) clearances per year for JXM
| Year | Clearances | Avg. review days |
|---|---|---|
| 2017 | 2 | 242 |
| 2018 | 1 | 55 |
| 2019 | 1 | 241 |
| 2022 | 1 | 189 |
| 2024 | 1 | 29 |
Compare with all 510(k) review times · Search every JXM clearance
Top JXM applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Syva Co. | 13 | 2000-01-27 |
| Abbott Laboratories | 8 | 2002-03-13 |
| Roche Diagnostic Systems, Inc. | 7 | 1999-02-11 |
| Healgen Scientific,, LLC | 4 | 2017-08-02 |
| Princeton BioMeditech Corp. | 4 | 1999-04-15 |
37 more applicants have JXM clearances. See the full list in Caduvo.
Most recent JXM clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K243498 | Microgenics Corporation | Alinity c Benzodiazepines Reagent Kit | 2024-12-11 | 29 |
| K221765 | Roche Diagnostics | ONLINE DAT Benzodiazepines II | 2022-12-23 | 189 |
| K190968 | Microgenics Corporation | CEDIA Benzodiazepine Assay | 2019-12-09 | 241 |
| K173963 | Microgenics Corporation | DRI Benzodiazepine Assay | 2018-02-21 | 55 |
| K163590 | Psychemedics Corporation | Psychemedics Microplate EIA for Benzodiazepines in Hair | 2017-09-15 | 269 |
Recalls for JXM devices
81 product recalls in 3 recall events; 0 initiated in the last five years and 0 still open. Most recent: 2020-07-13.
| Year | Recalls |
|---|---|
| 2020 | 2 |
Frequently asked questions
What is FDA product code JXM?
JXM is the FDA product code for enzyme immunoassay, benzodiazepine. It is a Class II device, regulated under 21 CFR 862.3170 and reviewed by the Clinical Toxicology panel.
What device class is JXM?
Class II, regulation 21 CFR 862.3170. Typical premarket route: 510(k).
How long does a 510(k) take for product code JXM?
Across 90 cleared submissions the average was 87 days from receipt to decision (median 59).
Which companies have the most JXM clearances?
Syva Co. (13); Abbott Laboratories (8); Roche Diagnostic Systems, Inc. (7); Healgen Scientific,, LLC (4); Princeton BioMeditech Corp. (4).
Have JXM devices been recalled?
Yes: 81 product recalls across 3 recall events; the most recent began 2020-07-13.
Next steps
- Run an FDA pathway report with predicate devices for product code JXM
- Run a recall and safety report across every JXM manufacturer
- Watch product code JXM for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Clinical Toxicology product codes · FDA product code lookup · 510(k) database search · 510(k) review times